Governance Documents

Governance Documents

Documents	Title
Add Files Code of Business Conduct and Ethics 61.1 KB	Code of Business Conduct and Ethics
Add Files Insider Trading 70 KB	Insider Trading
Add Files Internal Enforcement Plan (Hebrew) 552.4 KB	Internal Enforcement Plan (Hebrew)

Press Releases View all

September 25, 2019

BioLineRx Announces Dosing of First Patient in Part 2 of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors

September 25, 2019

BioLineRx Announces Dosing of First Patient in Part 2 of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors

September 3, 2019

BioLineRx Successfully Completes Dose-Escalation Part of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors

Upcoming Events View all